CHICAGO EQUITY PARTNERS LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q3 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2018$713,000
-50.2%
387,565
-49.1%
0.03%
-31.0%
Q3 2018$1,431,000
+40.3%
761,0350.0%0.04%
+35.5%
Q2 2018$1,020,000
-41.5%
761,035
-8.3%
0.03%
-44.6%
Q1 2018$1,743,000
+52.6%
829,769
-9.9%
0.06%
+60.0%
Q4 2017$1,142,000
-6.2%
920,900
-13.8%
0.04%
-7.9%
Q3 2017$1,218,000
-34.2%
1,068,300
-33.6%
0.04%
-24.0%
Q2 2017$1,852,0001,610,0650.05%
Other shareholders
NOVAVAX INC shareholders Q3 2017
NameSharesValueWeighting ↓
Parametrica Management Ltd 61,882$438,0002.76%
BB BIOTECH AG 8,330,000$58,893,0001.87%
Cormorant Asset Management, LP 1,600,000$11,312,0001.81%
HARVEY CAPITAL MANAGEMENT INC 623,950$4,411,0001.76%
WILLIAM HARRIS INVESTORS INC 488,666$3,455,0000.98%
Eventide Asset Management 2,097,500$14,829,0000.86%
AWM Investment Company, Inc. 400,000$2,828,0000.55%
NORTHPOINTE CAPITAL LLC 507,344$3,587,0000.47%
Rock Springs Capital Management LP 715,000$5,055,0000.41%
Opus Point Partners Management, LLC 100,000$707,0000.39%
View complete list of NOVAVAX INC shareholders